What is known and objective? Fibromyalgia is a painful disease affecting 1-2% of the United States population. However, efficacy data are limited for the SNRI venlafaxine despite its use in nearly a quarter of patients with fibromyalgia. Results were classified as primary studies or review articles based on abstract review.
READ FULL ARTICLE From Wiley Online Library